Shire Receives Buy Rating from Deutsche Bank (SHP)
Shire (LON:SHP)‘s stock had its “buy” rating reiterated by research analysts at Deutsche Bank in a report released on Thursday, Stock Ratings Network.com reports. They currently have a GBX 2,660 ($42.68) price objective on the stock. Deutsche Bank’s price objective points to a potential upside of 11.72% from the stock’s previous close.
Shire (LON:SHP) traded down 0.25% during mid-day trading on Thursday, hitting GBX 2381.00. 1,062,366 shares of the company’s stock traded hands. Shire has a one year low of GBX 1682.00 and a one year high of GBX 2602.00. The stock has a 50-day moving average of GBX 2432.08 and a 200-day moving average of GBX 2167.18. The company’s market cap is £13.086 billion.
A number of other firms have also recently commented on SHP. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Shire in a research note to investors on Tuesday. They now have a GBX 3,000 ($48.13) price target on the stock. Separately, analysts at Goldman Sachs Group Inc. reiterated a “conviction-buy” rating on shares of Shire in a research note to investors on Monday. Finally, analysts at BNP Paribas reiterated an “outperform” rating on shares of Shire in a research note to investors on Wednesday, October 2nd. They now have a GBX 2,700 ($43.32) price target on the stock. One analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of GBX 2,035.02 ($32.65).
Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.